Glucosamine API
Biologically derived, pharmaceutical-grade glucosamine for joint health
As individuals age, the cartilage gradually deteriorates, causing pain and discomfort.
Glucosamine API is therefore considered a Symptomatic Slow Acting Drug for the symptomatic treatment of mild knee osteoarthritis and joint discomfort, and demonstrates the ability to reduce joint pain and improve mobility.1 (este numero es la refrencia) 1) Ogata T, et al. Effects of glucosamine in patients with osteoarthritis of the knee: a systematic review and meta-analysis Clin Rheumatol. 2018 Sep;37(9):2479-2487.
What is glucosamine API?
Our glucosamine API is a high-purity, biologically derived ingredient for pharmaceutical formulations targeting osteoarthritis and joint discomfort. Harnessing decades of technical and regulatory expertise, we manufacture our pharmaceutical-grade glucosamine API according to strict GMP quality standards, ensuring it complies with US and EU Pharmacopoeias.
Glucosamine API is available in three versatile forms:
- Glucosamine hydrochloride
- Glucosamine sulfate sodium chloride
- Glucosamine sulfate potassium chloride
With Bioiberica as your innovation partner, you can bring innovative, safe and life-changing mobility solutions to market faster, easier and with greater success.
Glucosamine for joint health: How does it work?
Glucosamine is a precursor for the synthesis of glycosaminoglycans (GAG), like hyaluronic acid – a vital component found in most connective tissues and therefore crucial for joint health.
As we age, our capacity to produce the substances that support cartilage structure diminishes, gradually leading to increased pain and decreased mobility. Our glucosamine API is classed as a symptomatic slow acting drug for mild knee osteoarthritis, providing effective relief from joint discomfort.
Pioneering pharmaceutical excellence
With our glucosamine API we can support the development of quality-assured health and nutrition solutions that are as reliable, as they are powerful.
Regulatory dossiers submitted to key health authorities and referenced in different drug applications:
Glucosamine hydrochloride
- European Health Authorities
- Swissmedic
- EAEU and Uzbekistan MoH
- China CDE
Glucosamine sulfate sodium chloride
- European Health Authorities
- EAEU and Uzbekistan MoH
- Russian MoH (Normative Documentation)
- Taiwan FDA
Glucosamine sulfate potassium chloride
- European Health Authorities
Product information sheet
Explore the power of our glucosamine API in our comprehensive product information sheet and learn how we support you in the formulation of effective mobility solutions for the pharma market.
Do you have any product-specific questions?
Need more information or want to order a product sample? Submit your queries via the form and our experts will respond with the insights you need.